Warning Signs of Pancreatic Cancer and Advances in Treatment

Learn the early warning signs of pancreatic cancer. Explore the latest treatment advances from AARP. Early detection and new therapies improve outcomes every day.

My Friend’s Mom

Doctors diagnosed my best friend’s mother with Stage 4 pancreatic cancer. The news devastated us. The illness was terminal. Doctors could only offer palliative care and hospice referrals. My friend felt heartbroken for her mom, and I shared her sadness. Her mom was a vibrant, active woman. Everyone in her Connecticut community loved her. At the time, my friend and I managed her beauty salon in St. Louis. Taking time away posed a challenge. Still, she made every effort to visit her mom. She cared for her until the very end.

Recently, AARP published a story about similar situations. I will not share more details about my friend’s mom. However, I encourage you to read this piece. It will give you a clearer understanding. I also included a link to sign up for AARP. You can access more helpful health information there.

By Cheryl Platzman Weinstock and Rachel Nania
Updated April 06, 2026

AARP

• Pancreatic cancer survival has more than doubled over the past 20 years.
• Clinical trials show promise for targeted therapies. These include drugs aimed at a specific gene mutation.
• Researchers study AI tools, blood tests, and vaccines. They hope to catch the disease sooner and prevent recurrence.

Catching the Disease Early

Twenty years ago, a pancreatic cancer diagnosis devastated patients. Doctors rarely caught the cancer early. The pancreas sits behind the stomach. This location hides tumors well. Many warning signs appear only in later stages. People often overlook abdominal discomfort, back pain, unintended weight loss, and fatigue. Patients write them off as minor issues.

Dr. Shubham Pant works at the MD Anderson Cancer Center in Houston. He explains that pancreatic cancer sits silently in the body. It only shows up when it reaches an advanced stage.

Today, the five-year survival rate has more than doubled. The American Cancer Society reports a 44 percent survival rate for early detection. This happens when the tumor remains small and confined to the pancreas. This scenario applies to about 16 percent of diagnoses.

Dr. Brian Wolpin works at Harvard Medical School. He also co-directs a tumor center in Boston. He notes that medical advances help prolong lives. Doctors have improved systemic treatments like chemotherapy. They also deliver radiation more precisely. Breakthroughs in targeted therapies generate major excitement in the field.

Warning Signs of Pancreatic Cancer

The American Cancer Society expects 67,530 new diagnoses in 2026. Watch for these common symptoms:

1. Abdominal discomfort that radiates to the back
2. New-onset diabetes or worsening blood sugar levels
3. Dark urine and light-colored stool
4. Jaundice (yellowing of skin and eyes)
5. Itchy skin
6. Nausea and vomiting
7. Extreme fatigue
8. Loss of appetite and unintended weight loss

Treatment works best when doctors catch the cancer early. Let us look at recent progress in research and treatment.

Advances in Detection and Treatment

The Great Promise of Targeted Therapy

Researchers learn more every day about pancreatic cancer cells. They use this knowledge to develop targeted therapies. These medications attack specific changes in the cells to stop growth.

Dr. Michael Pishvaian directs research at Johns Hopkins. He explains that targeted therapy relies on specific molecular changes. A gene mutation or protein overexpression acts as an Achilles’ heel. Drugs can shut down this activity. This significantly slows or reverses cancer growth.

Targeting the KRAS Gene

Researchers target the KRAS gene mutation. Most pancreatic cancer patients have this mutation. Pishvaian reports a tidal wave of new therapies targeting KRAS. Early data show promising results.

Pant explains how these experimental therapies work. They turn the mutation off like a light switch. A KRAS mutation keeps the switch stuck in the “on” position. Inhibitors bind to the switch and turn it off. This action kills the cancer cells.

Scientists also study how to stop cancer before it starts. Researchers at Penn Medicine tested KRAS inhibitors on mice. They targeted precancerous lesions. The mice showed slower tumor development. Mice treated before developing tumors survived nearly twice as long.

Dr. Robert Vonderheide co-authored the study. He noted in a statement that cancer interception represents the next frontier. He believes intercepting abnormalities early will change the game. Doctors also see progress with other targets. Molecular testing remains crucial for patients today.

Using Artificial Intelligence to Discover Cancer

Imaging scans miss early pancreatic cancer 30 percent of the time. Doctors miss half of all cases until later stages.

Dr. Elliot Fishman works at Johns Hopkins School of Medicine. He believes we must do better. He uses artificial intelligence to train computers. The computers read CT scans to find small tumors early. Surgeons can then remove them. Fishman screens thousands of patients with high accuracy.

Researchers use AI in other ways too. Early cancers affect the normal body. AI might spot changes in the liver or spleen. This points to an elevated risk. Scientists also use AI to read medical records and predict cancer risk.

Using Blood Tests to Detect Pancreatic Cancer Early

Doctors use simple tests for other cancers. Soon, urine or blood tests might screen for pancreatic cancer. Body fluids hold fragments of tumor-cell DNA. Scientists make progress on these tests. Pant says reliable screening tests remain a few years away.

Exploring a Vaccine for Pancreatic Cancer

A 2023 clinical trial showed great promise. Researchers at Memorial Sloan Kettering Cancer Center tested a personalized mRNA vaccine. This vaccine prevented the most common type of pancreatic cancer from returning in half the participants. The trial continues today.

Dr. Vinod Balachandran co-authored the study. He feels excited to see vaccines enlist the immune system. Patients urgently need better treatments. This method might treat other deadly cancers too.

Know and Lower Your Risk Factors

Dr. James Farrell directs the Yale Center for Pancreatic Diseases. He stresses the importance of knowing your risk factors. You must watch for family history or pancreas cysts. Pay attention to new-onset diabetes. Early diagnosis improves patient outcomes.

You can lower your risk by making healthy lifestyle choices. Quit smoking, stop drinking alcohol, and maintain a healthy weight.

• Smoking causes about 25 percent of pancreatic cancers. Cigars and smokeless tobacco also raise your risk.
• People with a high BMI face a 20 percent higher risk. Type 2 diabetes affects overweight adults more often. This condition raises cancer risk, especially for people over 50.
• Alcohol causes chronic pancreatitis. This inflammation links directly to pancreatic cancer.

Unchangeable Risk Factors

You cannot change some risk factors. You must share them with your doctor.

• Genetics play a role. Tell your doctor about your family history. Ask about screening options.
• Family history of breast or ovarian cancer matters. BRCA mutations raise your risk. Lynch syndrome links to colon cancer and pancreatic cancer.

Age, gender, and race also affect your risk. Men develop this cancer slightly more often than women. The risk goes up as you age. African Americans face the highest risk of any racial group.

Editor’s Note: This story, originally published on Feb. 4, 2022, was updated with new information on April 6, 2026

About

DISC Health

The Health Equity Action Lab (HEAL) is an initiative by Dynasty Interactive Screen Community aimed at addressing health disparities in the U.S. and globally. By engaging media and stakeholders, HEAL seeks to reduce health inequalities and raise awareness. Their approach includes overcoming socio historical barriers and confronting the institutional, social, and political factors that perpetuate healthcare inequality.

Learn more about DISC Health

Learn more about the health education partnership:

Howard University Faculty Practice Plan & Howard University Hospital Partner with DISC Health Initiative to Expand Health Education Nationwide

Howard University Hospital (HUH)

Howard University Hospital, established in 1862 as Freedmen’s Hospital, has a rich history of serving African Americans and training top medical professionals. Located in Washington, D.C., it is the only teaching hospital on the campus of a historically Black university. HUH is a Level 1 Trauma Center and a critical healthcare provider for underserved populations. It offers advanced medical services, including robotic surgery, and has received numerous accolades for excellence in specialties like heart care, stroke treatment, and radiology.

Learn more about Howard University Hospital (HUH)

Howard University Faculty Practice Plan (FPP)

The Howard University Faculty Practice Plan is a multi-specialty physician group in Washington, D.C., dedicated to advancing healthcare and eliminating health disparities. It offers comprehensive services, including primary and specialty care, mental health, imaging, and cancer care, all connected to Howard University Hospital. FPP emphasizes patient-centered, respectful care for the diverse community and provides free health screenings and events to promote wellness.

Learn more about Howard University Faculty Practice Plan (FPP).

#PancreaticCancer #CancerAwareness #AARP #HealthNews #EarlyDetection #Oncology #CancerResearch #Healthcare #Wellness #MedicalAdvances